Tuesday, April 25, 2006

drug companies against us

Big name pharmaceuticals have paid generic manufacturers to NOT make generic versions of their drugs when patents have expired -- and now are doing it again??

The winners? The small manufacturers make money for doing nothing. The big drug companies get to keep charging monopolistic prices for drugs even after patents are expired.

The losers? Anybody who has to pay for the drugs -- insurance companies and ESPECIALLY patients.

This is collusion, anti-market collusion, pure and simple. And it's another point of proof to demonstrate that contrary to GOP theology, the market left to itself will NOT necessarily produce an Adam-Smith's-Invisible-Hand like free market.

2 Comments:

Anonymous Anonymous said...

Well said and so true!

I took zyprexa which was ineffective for my condition and gave me diabetes.

Zyprexa, which is used for the treatment of psychiatric disorders, such as schizophrenia and bipolar disorder, accounted for 32% of Eli Lilly's $14.6 billion revenue last year.

Zyprexa is the product name for Olanzapine,it is Lilly's top selling drug.It was approved by the FDA in 1996 ,an 'atypical' antipsychotic a newer class of drugs without the motor side effects of the older Thorazine.Zyprexa has been linked to causing diabetes and pancreatitis.

Did you know that Lilly made nearly $3 billion last year on diabetic meds, Actos,Humulin and Byetta?

Yes! They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

I was prescribed Zyprexa from 1996 until 2000.
In early 2000 i was shocked to have an A1C test result of 13.9 (normal is 4-6) I have no history of diabetes in my family.
----
Daniel Haszard http://www.zyprexa-victims.com

11:25 AM  
Blogger jomana yusef said...

https://decor-ksa.com/
https://3kary.com/property-status/warehouses-for-rent/

8:53 PM  

Post a Comment

<< Home